Events
Nerviano Medical Sciences S.r.l. to present data on its ADC platform at the World ADC Summit 2023 in San Diego CA (Oct 16th-Oct 19th, 2023)
Nerviano Medical Sciences S.r.l., a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud to announce its participation to the World ADC 2023 summit that will be held in San Diego (CA) from October 16th to October 19th, 2023, with two poster presentations
(Click the title for the complete article)
Nerviano Medical Sciences Srl partecipa alla European Biotech Week 2023 / Nerviano Medical Sciences Srl participates in the European Biotech Week 2023
La EBW è una settimana di eventi e incontri in tutta Europa per raccontare le biotecnologie nei diversi settori di applicazione ad un pubblico vasto e diversificato, sottolineando il ruolo chiave che queste tecnologie hanno nel migliorare la qualità della vita di tutti noi.
(Click the title for the complete article)
Visit Accelera Team at the 57th Congress of the European Societies of Toxicology (EUROTOX 2023). Ljubljana, Slovenia, (September 10-13)
Visit Accelera Team at the 57th Congress of the European Societies of Toxicology (EUROTOX 2023). Ljubljana, Slovenia, (September 10-13)
(Click the title for the complete article)
Nerviano Medical Sciences S.r.l. Announces Clinical Data on NMS-03592088 selected for Oral Presentation at AACR Annual Meeting 2023
NERVIANO, 4 April 2023 – Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that data from the Phase I/II clinical study of NMS-03592088 in Acute Myeloid Leukemia will be reported in an oral presentation by Dr. Antonio Curti, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna, at the upcoming AACR Annual Meeting which will be held April 14 – 19, Orange County Convention Center, Orlando, Florida.
(Click the title for the complete article)
Visit Accelera Team at the SOT 2023 Annual Meeting in Nashville, Tennessee (March 19-23)
Visit Accelera Team
at the SOT 2023 Annual Meeting in Nashville, Tennessee
March 19 – 23
Booth #1214
Visit our booth for an overview of our services
(Click the title for the complete article)
Accelera sponsor del 21° congresso nazionale SITOX – Bologna (20-22 Febbraio 2023)
Accelera è Sponsor del 21° congresso nazionale SITOX che si svolgerà a Bologna il giorno 21 febbraio (dalle 11.00 alle 12.00), presenterà il poster “Valutazione preclinica della tossicità a carico del SNC nel soggetto pediatrico: tecniche istologiche in neonati di ratto”.
nella sessione P3 Farmaci
Numero del poster: P3/1
(Click the title for the complete article)
Nerviano Medical Sciences S.r.l. Shared Data on NMS-01940153E selected for Oral Presentation at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today shared data from the Company’s Phase I/II clinical study of NMS-01940153E in Hepatocellular carcinoma (HCC) in an oral presentation by Dr. Maria Reig at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) in Barcelona.
(Click the title for the complete article)
Nerviano Medical Sciences S.r.l. Announces a Poster Presentation on NMS-03602173 at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Nerviano Medical Sciences Srl, a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that preclinical data from the Company’s asset NMS-03602173 will be reported in a poster presentation by Dr. Paola Magnaghi at the upcoming EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) which will be held October 26-28, 2022 at the CCIB in Barcelona.
(Click the title for the complete article)
NMS-01940153E selected for Oral Presentation at 34th EORTC-NCI-AACR
NERVIANO, 18 October 2022 – Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that data from the Company’s Phase I/II clinical study of NMS-01940153E in Hepatocellular carcinoma (HCC) will be reported in an oral presentation by Dr. Maria Reig at the upcoming EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) which will be held October 26-28, 2022 at the CCIB in Barcelona.
(Click the title for the complete article)
We are ICT in Maastricht 2022
Where: MECC – Forum 100, 6229 GV Maastricht, Netherlands
When: September 18 to 21, 2022
The Dutch Society of Toxicology (NVT) is welcoming the global community to the XVIth International Congress of Toxicology in Maastricht, the Netherlands, from September 18 to 21, 2022.
Accelera s.r.l. will be present at the ICT in Maastricht Exhibition Booth # 37.
We look forward to see you soon!
Get an appointment with us! E-mail: Francesco.Sola@accelera.org